Core Viewpoint - AMN Healthcare Services reported a decline in revenue and earnings for the quarter ended September 2025, with a notable surprise in EPS performance compared to analyst expectations [1][3]. Financial Performance - Revenue for the quarter was $634.5 million, down 7.7% year-over-year, but exceeded the Zacks Consensus Estimate of $615.14 million by 3.15% [1]. - Earnings per share (EPS) was $0.39, a decrease from $0.61 in the same quarter last year, but significantly higher than the consensus estimate of $0.19, resulting in an EPS surprise of 105.26% [1]. Segment Performance - Physician and leadership solutions reported revenue of $178.21 million, slightly above the average estimate of $175.12 million, but down 1.3% year-over-year [4]. - Nurse and allied solutions generated $361.48 million in revenue, surpassing the estimated $346.66 million, but reflecting a 9.5% decline compared to the previous year [4]. - Technology and workforce solutions achieved $94.81 million in revenue, exceeding the average estimate of $93.42 million, with an 11.8% year-over-year decrease [4]. Operating Income - Segment operating income for nurse and allied solutions was $28.76 million, above the estimated $24.57 million [4]. - Operating income for technology and workforce solutions was $30.89 million, below the average estimate of $33.09 million [4]. - Physician and leadership solutions had an operating income of $15.73 million, slightly above the estimated $15.37 million [4]. Stock Performance - AMN Healthcare shares returned 7.1% over the past month, outperforming the Zacks S&P 500 composite, which saw a 1.3% change [3]. - The stock currently holds a Zacks Rank of 5 (Strong Sell), indicating potential underperformance in the near term [3].

Core Insights - Appian (APPN) reported $187 million in revenue for Q3 2025, marking a year-over-year increase of 21.4% and exceeding the Zacks Consensus Estimate by 7.58% [1] - The company's EPS for the quarter was $0.32, significantly higher than the $0.15 reported a year ago, resulting in a surprise of 540% compared to the consensus estimate of $0.05 [1] Financial Performance - Subscriptions gross margin was reported at 87.9%, slightly below the estimated 88.1% [4] - Professional services gross margin stood at 30.9%, surpassing the average estimate of 28% [4] - Revenue from professional services reached $39.82 million, exceeding the estimated $33.67 million and reflecting a year-over-year increase of 28.7% [4] - Subscription revenue was $147.19 million, above the average estimate of $140.16 million, representing a year-over-year growth of 19.6% [4] Market Performance - Over the past month, Appian's shares have returned -0.7%, while the Zacks S&P 500 composite increased by 1.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Core Viewpoint - Alcon is expected to report quarterly earnings of $0.77 per share, a decline of 4.9% year-over-year, with revenues projected at $2.59 billion, reflecting a 6.5% increase compared to the previous year [1] Earnings Projections - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating analysts' reassessment of their initial projections [1][2] Key Metrics Forecast - Analysts predict 'Net Sales- Total Surgical' to be $1.42 billion, a 6.1% increase from the prior-year quarter [4] - 'Net Sales- Total Vision Care' is expected to reach $1.17 billion, suggesting a 7.1% year-over-year change [4] Detailed Sales Estimates - 'Net Sales- Total Surgical- Consumables' is estimated at $743.89 million, reflecting a 6.1% increase from the previous year [5] - 'Net Sales- Total Surgical- Equipment/other' is projected at $245.51 million, indicating a 14.2% year-over-year increase [5] - 'Net Sales- Total Vision Care- Contact lenses' is expected to be $724.58 million, a 9.1% increase year-over-year [6] - 'Net Sales- Total Vision Care- Ocular health' is forecasted at $448.60 million, showing a 4.1% change from the prior-year quarter [6] Regional Sales Forecast - 'Net Sales- Total Surgical- Implantables' is projected to reach $430.00 million, a 1.9% increase from the previous year [7] - 'Revenues- Other revenues' are expected to be $19.52 million, indicating a 7.1% decline year-over-year [7] - 'Net sales by region- United States' is forecasted at $1.16 billion, reflecting a 4.6% year-over-year increase [7] - 'Net sales by region- International' is expected to reach $1.43 billion, suggesting an 8.2% increase from the prior-year quarter [8] Stock Performance - Alcon shares have decreased by 2.9% in the past month, contrasting with the Zacks S&P 500 composite's increase of 1.3% [8] - With a Zacks Rank 2 (Buy), Alcon is anticipated to outperform the overall market performance in the near term [8]

Wall Street analysts forecast that DuPont de Nemours (DD) will report quarterly earnings of $1.04 per share in its upcoming release, pointing to a year-over-year decline of 11.9%. It is anticipated that revenues will amount to $2.63 billion, exhibiting a decrease of 17.7% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 15.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their init ...

Core Insights - GoodRx Holdings, Inc. reported revenue of $196.03 million for the quarter ended September 2025, reflecting a year-over-year increase of 0.4% [1] - The earnings per share (EPS) for the same period was $0.08, unchanged from the previous year, but below the consensus estimate of $0.09, resulting in an EPS surprise of -11.11% [1] - The reported revenue exceeded the Zacks Consensus Estimate of $193.43 million, indicating a positive surprise of +1.34% [1] Financial Performance Metrics - Monthly Active Consumers stood at 5, matching the average estimate from three analysts [4] - Subscription plans reached 671, slightly above the average estimate of 662 from two analysts [4] - Revenue from prescription transactions was $127.29 million, below the average estimate of $131.26 million, representing a year-over-year decline of -9.3% [4] - Revenue from other sources was $4.64 million, slightly above the estimated $4.5 million, but down -14% compared to the previous year [4] - Revenue from pharmaceutical manufacturer solutions was $43.37 million, exceeding the average estimate of $37.06 million, marking a significant year-over-year increase of +54.4% [4] - Subscription revenue was reported at $20.72 million, slightly above the estimate of $20.26 million, but down -2.7% year-over-year [4] Stock Performance - GoodRx shares have declined by -27.7% over the past month, contrasting with a +2.1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Intapp reported revenue of $139.03 million for the quarter ended September 2025, reflecting a 17% increase year-over-year and exceeding the Zacks Consensus Estimate of $135.48 million by 2.62% [1] - The company's EPS for the quarter was $0.24, up from $0.21 in the same quarter last year, surpassing the consensus EPS estimate of $0.19 by 26.32% [1] Financial Performance Metrics - Cloud annual recurring revenue (Cloud ARR) reached $401.4 million, exceeding the average estimate of $394.3 million from five analysts [4] - Total annual recurring revenue (Total ARR) was reported at $504.1 million, compared to the estimated $494.72 million from five analysts [4] - Total revenues from SaaS amounted to $97.52 million, slightly above the average estimate of $96.35 million from six analysts [4] - Professional services revenue was $12.32 million, below the average estimate of $13.81 million, marking an 8.3% decrease year-over-year [4] - Total license revenue was $29.19 million, surpassing the average estimate of $25.31 million from six analysts [4] - Gross profit from SaaS was $79.66 million, slightly above the average estimate of $79.45 million from four analysts [4] - Gross profit from licenses was $27.62 million, exceeding the average estimate of $23.59 million from four analysts [4] - Gross profit from professional services was reported at -$3.45 million, worse than the average estimate of -$0.63 million from three analysts [4] Stock Performance - Intapp's shares have returned -4.5% over the past month, contrasting with the Zacks S&P 500 composite's increase of 2.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Kratos (KTOS) reported $347.6 million in revenue for Q3 2025, a 26% year-over-year increase, with an EPS of $0.14 compared to $0.11 a year ago, exceeding both revenue and EPS estimates [1][4] Revenue Breakdown - Product sales reached $230.2 million, surpassing the average estimate of $191.59 million, reflecting a 33.8% year-over-year increase [4] - Unmanned Systems generated $87.2 million, exceeding the estimated $77.18 million, marking a 35.8% increase from the previous year [4] - Kratos Government Solutions reported $260.4 million, above the $248.03 million estimate, representing a 23% year-over-year growth [4] - Service revenues totaled $117.4 million, below the average estimate of $133.04 million, with a 13% increase year-over-year [4] Profitability Metrics - Gross profit from service revenues was $26.2 million, lower than the $33.11 million estimate [4] - Gross profit from product sales was $50.9 million, exceeding the $44.6 million estimate [4] - Operating income for Kratos Government Solutions was $13.7 million, below the $16.75 million estimate [4] Stock Performance - Kratos shares have returned -9.1% over the past month, contrasting with the Zacks S&P 500 composite's +2.1% change, but the stock holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Insights - Advanced Micro Devices (AMD) reported a revenue of $9.25 billion for the quarter ended September 2025, reflecting a year-over-year increase of 35.6% and surpassing the Zacks Consensus Estimate by 6% [1] - Earnings per share (EPS) for the quarter was $1.20, up from $0.92 in the same quarter last year, with an EPS surprise of 2.56% over the consensus estimate of $1.17 [1] Revenue Breakdown - Data Center revenue reached $4.34 billion, exceeding the average estimate of $4.18 billion by analysts, marking a year-over-year increase of 22.3% [4] - Embedded revenue was reported at $857 million, falling short of the average estimate of $903.49 million, representing a decline of 7.6% year over year [4] - Gaming revenue surged to $1.3 billion, significantly surpassing the average estimate of $1.05 billion, with a remarkable year-over-year growth of 181% [4] - Client revenue amounted to $2.75 billion, exceeding the average estimate of $2.6 billion, reflecting a year-over-year increase of 46.2% [4] Stock Performance - AMD shares have returned 27.5% over the past month, outperforming the Zacks S&P 500 composite, which saw a change of 2.1% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Viewpoint - FS KKR Capital (FSK) is expected to report a quarterly earnings per share (EPS) of $0.57, reflecting a 23% decline year-over-year, with revenues projected at $376.07 million, a decrease of 14.7% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.4% in the last 30 days, indicating a reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Metrics Forecast - Analysts predict 'Investment income- Fee income' to be $9.82 million, down 53.2% year-over-year [5]. - The estimate for 'Investment income- Dividend and other income' is $74.61 million, indicating a 16.6% increase from the previous year [5]. - 'Investment income- Paid-in-kind interest income' is expected to reach $49.79 million, reflecting a 24.6% decline year-over-year [5]. - 'Investment income- Interest income' is forecasted at $239.33 million, down 17.5% from the prior-year quarter [6]. Stock Performance - Over the past month, FS KKR Capital shares have returned -1.6%, while the Zacks S&P 500 composite has increased by 2.1% [6]. - Currently, FS KKR Capital holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the overall market in the near future [6].

Core Insights - Bandwidth reported revenue of $191.9 million for the quarter ended September 2025, a decrease of 1% year-over-year, with EPS at $0.36 compared to $0.43 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $189.9 million by 1.05%, while the EPS fell short of the consensus estimate of $0.38 by 5.26% [1] Financial Performance Metrics - Net retention rate was reported at 105%, below the estimated 110.6% by analysts [4] - International revenue reached $26.15 million, surpassing the estimated $24.6 million, reflecting a year-over-year increase of 10.8% [4] - North American revenue was $165.74 million, slightly below the estimate of $165.77 million, indicating a year-over-year decline of 2.7% [4] - Revenue from messaging surcharges was $50.09 million, exceeding the average estimate of $47.04 million [4] - Revenue from cloud communications was reported at $141.81 million, below the estimated $143.27 million [4] Stock Performance - Bandwidth shares have returned +4.9% over the past month, outperforming the Zacks S&P 500 composite's +3.6% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]